Thermosome Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series A
- Investors
-
7
Thermosome General Information
Description
Developer of a drug development platform designed to improve antitumor responses in cancer treatment. The company's platform leverages a proprietary drug delivery technology, which exploits a novel mechanism of action called intravascular drug release that is used to treat locally advanced solid tumors with targeted chemotherapy, enabling patients to begin cancer treatment quickly with low side effects and increased efficacy.
Contact Information
Website
www.thermosome.comCorporate Office
- Am Klopferspitz 19
- 82152 Planegg
- Germany
Corporate Office
- Am Klopferspitz 19
- 82152 Planegg
- Germany
Thermosome Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | Completed | Clinical Trials - Phase 1 | ||||
| 2. Early Stage VC | 31-Aug-2016 | Completed | Clinical Trials - Phase 1 | |||
| 1. Grant | 06-Apr-2016 | $3.03M | Completed | Startup |
Thermosome Comparisons
Industry
Financing
Details
Thermosome Competitors (54)
One of Thermosome’s 54 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| Imunon | Corporation | Lawrenceville, NJ | ||||
| Pure MHC | Formerly VC-backed | Austin, TX | ||||
| iOmx Therapeutics | Venture Capital-Backed | Munich, Germany | ||||
| MaveriX Oncology | Venture Capital-Backed | Palo Alto, CA |
Thermosome Patents
Thermosome Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4527380-A1 | Lipid nanoparticles | Inactive | 19-Sep-2023 | ||
| EP-4780425-A1 | Lipid nanoparticles | Pending | 19-Sep-2023 | ||
| JP-2026534185-A | Lipid nanoparticles | Pending | 19-Sep-2023 | ||
| WO-2025061856-A1 | Lipid nanoparticles | Inactive | 19-Sep-2023 | ||
| AU-2024345757-A1 | Lipids containing an oligoglycerol group | Pending | 19-Sep-2023 | C07C219/08 |
Thermosome Signals
Thermosome Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arnika Beteiligungen Family Office | Family Office | Minority | ||
| Bayern Kapital | Venture Capital | Minority | ||
| Bundesministerium für Bildung und Forschung | Government | Minority | ||
| High-Tech Gründerfonds | Venture Capital | Minority | ||
| German Ministry of Education and Research | Government |
Thermosome FAQs
-
When was Thermosome founded?
Thermosome was founded in 2015.
-
Where is Thermosome headquartered?
Thermosome is headquartered in Planegg, Germany.
-
What is the size of Thermosome?
Thermosome has 11 total employees.
-
What industry is Thermosome in?
Thermosome’s primary industry is Drug Discovery.
-
Is Thermosome a private or public company?
Thermosome is a Private company.
-
What is Thermosome’s current revenue?
The current revenue for Thermosome is .
-
How much funding has Thermosome raised over time?
Thermosome has raised $5.15M.
-
Who are Thermosome’s investors?
Arnika Beteiligungen Family Office, Bayern Kapital, Bundesministerium für Bildung und Forschung, High-Tech Gründerfonds, and German Ministry of Education and Research are 5 of 7 investors who have invested in Thermosome.
-
Who are Thermosome’s competitors?
Voyager Therapeutics, Imunon, Pure MHC, iOmx Therapeutics, and MaveriX Oncology are some of the 54 competitors of Thermosome.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process